Abu Dhabi has announced two major partnerships with the Massachusetts Institute of Technology (MIT) to strengthen cancer research and speed up the development of new medical treatments. The agreements aim to improve cancer care by combining advanced research, artificial intelligence, and precision medicine with Abu Dhabi’s growing life sciences sector.
The collaborations were announced during the BIO International Convention 2026 in San Diego. They bring together the Department of Health – Abu Dhabi (DoH), Future Health – A Global Initiative by Abu Dhabi, and MIT’s Koch Institute for Integrative Cancer Research. Together, they plan to create new opportunities for research, innovation, talent development, and better patient care.
The first agreement creates a strategic partnership between the Department of Health – Abu Dhabi and the MIT Koch Institute for Integrative Cancer Research. The partnership will focus on AI-powered cancer research, translational science, and bioconvergence technologies that help move discoveries from laboratories into hospitals and clinics.
The project will use Abu Dhabi’s expanding healthcare and research ecosystem to connect scientists, doctors, engineers, and technology experts. By combining research knowledge with advanced healthcare infrastructure, the partners hope to develop and test new medical solutions more quickly.
The collaboration is expected to support the creation of new cancer treatments, improve disease detection, and expand the use of precision medicine. Precision medicine uses information about a person’s genes, health, and lifestyle to provide treatments that are better matched to each patient.
Alongside this partnership, Future Health has become a founding member of the MIT-led BioConvergence Cancer Alliance. The alliance brings together more than 1,000 scientists, engineers, and researchers from around the world who work on improving cancer research and healthcare innovation.
By joining the alliance, Future Health will gain access to international scientific expertise and research networks. The partnership is expected to encourage knowledge sharing, strengthen research capabilities, and support the development of new technologies that can improve patient outcomes.
The initiative will also help attract skilled researchers, healthcare professionals, and innovators to Abu Dhabi. Building a strong scientific community is an important part of the emirate’s long-term strategy to become a global center for healthcare, biotechnology, and medical research.
Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said cancer remains one of the world’s biggest health challenges. She said solving complex health problems requires cooperation between researchers, healthcare providers, governments, and technology experts from different countries.
She added that the new partnerships reflect Abu Dhabi’s commitment to building a connected healthcare ecosystem where science, technology, innovation, and medical care work together. The goal is to support earlier diagnosis, more personalized treatment, and better health outcomes for patients.
Matthew Vander Heiden, Director of MIT’s Koch Institute for Integrative Cancer Research, said important advances in cancer care happen when scientific discovery, technology, and practical healthcare work together. He said the collaboration with Abu Dhabi creates new opportunities for joint research and faster scientific progress in oncology and precision medicine.
Artificial intelligence is becoming an important tool in cancer research. AI can help researchers study large amounts of medical data, identify disease patterns, improve medical imaging, and support doctors in making faster and more accurate treatment decisions. Combining AI with precision medicine could lead to more effective therapies for many types of cancer.
Abu Dhabi has continued to invest heavily in healthcare, medical technology, and scientific research over recent years. The emirate has expanded its hospitals, research centers, and biotechnology programs while building partnerships with leading international institutions. These investments aim to improve healthcare services for residents while contributing to global medical innovation.
The new collaborations with MIT represent another step in that strategy. By bringing together international research expertise and Abu Dhabi’s growing life sciences ecosystem, the partnerships aim to accelerate scientific discovery and turn research into practical medical solutions.
As cancer remains one of the leading causes of death worldwide, stronger international cooperation is becoming increasingly important. The new agreements are expected to support long-term advances in research, encourage innovation across the healthcare sector, and help deliver better diagnosis, treatment, and care for patients both in Abu Dhabi and around the world.
